These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5371663)

  • 1. Recent investigations on the biological properties of rifampicin.
    Furesz S
    Acta Tuberc Pneumol Belg; 1969; 60(3):266-9. PubMed ID: 5371663
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlations between the biological properties and structure of rifampicin].
    Sensi P
    G Ital Mal Torace; 1969; ():Suppl 2:40-9. PubMed ID: 5357138
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of rifampicin in experimental animals and in man].
    Curci G; Ninni A
    Lotta Tuberc; 1971; 41(3):354-66. PubMed ID: 5291093
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin, a new antitubercular bactericide].
    Thibault P
    Presse Med (1893); 1970 Feb; 78(11):501-2. PubMed ID: 5418624
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental and clinical studies on the metabolic fate of rifampicin in animals and in humans.
    Yokosawa A; Arai H; Sato H; Motomiya M; Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1973 Dec; 19(4):177-82. PubMed ID: 4768318
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of rifampicin on gamma-glutamyl-transferase in guinea-pigs (author's transl)].
    Papadimitriou J; Vamvalis C; Balodimos H; Calafati-Tjimaka H; Tjimakas C; Stavropoulos C
    Schweiz Rundsch Med Prax; 1980 Jan; 69(1):12-3. PubMed ID: 6102763
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rifampicin and isoniazid in the intermittent treatment of experimental tuberculosis in guinea-pigs].
    Daddi G; Lucchesi M; Mancini P
    Ann Ist Carlo Forlanini; 1969; 29(1):35-40. PubMed ID: 5405839
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics of rifomycin].
    Curci G; Ninni A; Iodice F
    Acta Tuberc Pneumol Belg; 1969; 60(3):276-87. PubMed ID: 5371665
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmaceutical view of rifampicin (author's transl)].
    Tsutsumi S; Sakamoto Y; Gido S
    Repura; 1974; 43(1):1-7. PubMed ID: 4610307
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research on the protective action of rifampicin administered intermittently in experimental tuberculosis in guinea pigs].
    Algeorge G; Sibilla S; Rudesco D
    Ann Pediatr (Paris); 1970 Oct; 17(10):674. PubMed ID: 5475418
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biological characteristics of rifampicin-resistant Mycobacterium tuberculosis].
    Klimenko MT
    Antibiotiki; 1984 Mar; 29(3):185-8. PubMed ID: 6428304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Animal experimental studies on the effect of rifampicin on pathogenic gas gangrene bacilli].
    Schallehn G
    Schweiz Med Wochenschr; 1969 Jul; 99(29):1057-9. PubMed ID: 5802010
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental study on rifamicin pharmacodynamics].
    Curci G; Ninni A; Di Mezza F
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):293-314. PubMed ID: 5307453
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifampicin. Interactions with other drugs].
    Salvá JA; Erill S
    Arch Farmacol Toxicol; 1975 Mar; 1(1):82-90. PubMed ID: 1231650
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 17. [General remarks on Rifampicin].
    Toscano F
    Minerva Med; 1969 Dec; 60(96):4783-9. PubMed ID: 5357543
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ability of rifadin (rifampicin) to cause fluorescence of the nucleic acids in cells].
    Autenshlius AI; Zikeev VV
    Lab Delo; 1973; 6():376. PubMed ID: 4129402
    [No Abstract]   [Full Text] [Related]  

  • 19. [Regulatory properties of RNA polymerase from rifampicin-resistant E. coli strain rpoB403].
    Kamzolova SG
    Biokhimiia; 1996 Aug; 61(8):1483-8. PubMed ID: 8962922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reports of the round table discussion on rifampicin. Introduction].
    Antognetti L
    Arch Maragliano Patol Clin; 1969; 25(5):345-9. PubMed ID: 5395550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.